Copyright
©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 392-394
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.392
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.392
Table 1 Benefit of HB vaccination of the low-dose strategy for three places with different economic development level and different endemicity
Place | |||
Longan | Shanghai | Jinan | |
HBsAg positive rate before vaccination (%) | 18.0 | 10.2 | 7.6 |
No. of neonates in 1987 | 7666 | 12000 | 18519 |
Direct benefit* | 286 | 345 | 562 |
Indirect benefit* | 683 | 1571 | 1852 |
Total benefit* | 969 | 1916 | 2414 |
Total cost* | 18 | 22 | 42 |
Net benefit* | 951 | 1893 | 2372 |
BCR | 52.7 | 85.8 | 57.9 |
DBCR | 15.5 | 15.4 | 13.5 |
BCR excluding cost of liver cancer | 23.6 | 67.9 | 34.8 |
DBCR excluding cost of liver cancer | 9.2 | 14.2 | 10.1 |
HBsAg-positive rate after vaccination (%) | 3.1 | 2.2 | 1.5 |
- Citation: Li H, Wang L, Wang SS, Gong J, Zeng XJ, Li RC, Nong Y, Huang YK, Chen XR, Huang ZN. Research on optimal immunization strategies for hepatitis B in different endemic areas in China. World J Gastroenterol 2000; 6(3): 392-394
- URL: https://www.wjgnet.com/1007-9327/full/v6/i3/392.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i3.392